Risk factors for diagnostic delay in Chinese patients with hereditary angioedema

被引:16
作者
Liu, S. [1 ,2 ,3 ,4 ]
Wang, X. [1 ,2 ,4 ,5 ]
Xu, Yingyang [1 ,2 ]
Xu, Qun [6 ,7 ]
Zhi, Yuxiang [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Dept Allergy, Beijing, Peoples R China
[2] Peking Union Med Coll Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Sch Clin Med, Beijing, Peoples R China
[4] Peking Union Med Coll, 1 Shuaifuyuan, Beijing 100730, Peoples R China
[5] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Key Lab Endocrinol, Natl Hlth Commiss,Dept Endocrinol, Beijing, Peoples R China
[6] Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Dept Epidemiol & Biostat,Inst Basic Med Sci, Beijing, Peoples R China
[7] Chinese Acad Med Sci, Peking Union Med Coll, Ctr Environm & Hlth Sci, Beijing, Peoples R China
关键词
D O I
10.2500/aap.2019.40.4234
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Hereditary angioedema (HAE) is still underdiagnosed or diagnosed after a serious delay. This study aimed to evaluate the diagnostic delay (DD) and misdiagnosis of HAE, and to explore the risk factors associated with a longer DD. Methods: An Internet-based survey was sent to 129 patients with type 1 and 2 HAE who presented to the Allergy Department, Peking Union Medical College Hospital between 1983 and 2017; 107 patients (82.9%) responded, among whom, a total of 96 patients provided complete information about medical visits. DD was divided into two subperiods according to the lower quartile, i.e., DD <= 6 years and DD > 6 years. Results: The median DD of all 96 patients with HAE was 11.04 years (interquartile range [IQR], 6.06-18.27 years). A significant difference (p < 0.001) in the median DD was found between different decades of onset, i.e., before 1999 (19.75 years [IQR, 13.58-29.50 years]), between 2000 and 2009 (8.67 years [IQR, 5.67-11.04 years]), and between 2010 and 2017 (3.79 years [IQR, 2.29-5.71 years]). Patients with a previous misdiagnosis experienced a longer median delay to complement 1 inhibitor HAE diagnosis (13.17 years [IQR, 7.40-20.50 years]) compared with patients without a previous misdiagnosis (median 6.96 years [IQR, 2.83-10.65 years]; p <= 0.001). According to the logistic regression analysis, a younger age of onset and earlier decade of onset were significant predictors of a DD of >6 years. The most frequently visited departments and most frequently misdiagnosed diseases were summarized. Conclusion: The median DD of patients with HAE was 11.04 years (IQR, 6.06-18.27 years). A younger age of onset and earlier decade of onset were predictors of a DD of >6 years. Seventy-five percent of the patients reported receiving more than one previous misdiagnosis. The patients with a previous misdiagnosis had longer DDs compared with patients without a misdiagnosis.
引用
收藏
页码:343 / 349
页数:7
相关论文
共 17 条
  • [1] Hereditary angioedema from the patient's perspective: A follow-up patient survey
    Banerji, Aleena
    Li, Yu
    Busse, Paula
    Riedl, Marc A.
    Holtzman, Nicole S.
    Li, Huamin Henry
    Davis-Lorton, Mark
    Bernstein, Jonathan A.
    Frank, Michael
    Castaldo, Anthony J.
    Long, Janet
    Zuraw, Bruce
    Lumry, William
    Christiansen, Sandra
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2018, 39 (03) : 212 - 223
  • [2] Canadian hereditary angioedema guideline
    Betschel, Stephen
    Badiou, Jacquie
    Binkley, Karen
    Hebert, Jacques
    Kanani, Amin
    Keith, Paul
    Lacuesta, Gina
    Yang, Bill
    Aygoeren-Puersuen, Emel
    Bernstein, Jonathan
    Bork, Konrad
    Caballero, Teresa
    Cicardi, Marco
    Craig, Timothy
    Farkas, Henriette
    Longhurst, Hilary
    Zuraw, Bruce
    Boysen, Henrik
    Borici-Mazi, Rozita
    Bowen, Tom
    Dallas, Karen
    Dean, John
    Lang-Robertson, Kelly
    Laramee, Benoit
    Leith, Eric
    Mace, Sean
    McCusker, Christine
    Moote, Bill
    Poon, Man-Chiu
    Ritchie, Bruce
    Stark, Donald
    Sussman, Gordon
    Waserman, Susan
    [J]. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2014, 10
  • [3] Hereditary angioedema: New findings concerning symptoms, affected organs, and course
    Bork, K
    Meng, G
    Staubach, P
    Hardt, J
    [J]. AMERICAN JOURNAL OF MEDICINE, 2006, 119 (03) : 267 - 274
  • [4] A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE)
    Bork, Konrad
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2016, 51 (02) : 183 - 192
  • [5] Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency
    Bork, Konrad
    Hardt, Jochen
    Witzke, Guenther
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 130 (03) : 692 - 697
  • [6] Hereditary angio-oedema in Denmark: a nationwide survey
    Bygum, A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (05) : 1153 - 1158
  • [7] Pediatric Hereditary Angioedema: Onset, Diagnostic Delay, and Disease Severity
    Christiansen, Sandra C.
    Davis, Donna K.
    Castaldo, Anthony J.
    Zuraw, Bruce L.
    [J]. CLINICAL PEDIATRICS, 2016, 55 (10) : 935 - 942
  • [8] Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group
    Cicardi, M.
    Aberer, W.
    Banerji, A.
    Bas, M.
    Bernstein, J. A.
    Bork, K.
    Caballero, T.
    Farkas, H.
    Grumach, A.
    Kaplan, A. P.
    Riedl, M. A.
    Triggiani, M.
    Zanichelli, A.
    Zuraw, B.
    [J]. ALLERGY, 2014, 69 (05) : 602 - 616
  • [9] A UK national audit of hereditary and acquired angioedema
    Jolles, S.
    Williams, P.
    Carne, E.
    Mian, H.
    Huissoon, A.
    Wong, G.
    Hackett, S.
    Lortan, J.
    Platts, V.
    Longhurst, H.
    Grigoriadou, S.
    Dempster, J.
    Deacock, S.
    Khan, S.
    Darroch, J.
    Simon, C.
    Thomas, M.
    Pavaladurai, V.
    Alachkar, H.
    Herwadkar, A.
    Abinun, M.
    Arkwright, P.
    Tarzi, M.
    Helbert, M.
    Bangs, C.
    Pastacaldi, C.
    Phillips, C.
    Bennett, H.
    El-Shanawany, T.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 175 (01) : 59 - 67
  • [10] Review of Select Practice Parameters, Evidence-Based Treatment Algorithms, and International Guidelines for Hereditary Angioedema
    Jose, Jaison
    Zacharias, Jamie
    Craig, Timothy
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2016, 51 (02) : 193 - 206